Voya Investment Management LLC grew its holdings in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 3.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 628,702 shares of the medical research company’s stock after acquiring an additional 23,795 shares during the period. Voya Investment Management LLC owned about 0.80% of RadNet worth $43,343,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Public Sector Pension Investment Board lifted its position in shares of RadNet by 82.9% in the 3rd quarter. Public Sector Pension Investment Board now owns 444,754 shares of the medical research company’s stock worth $31,847,000 after purchasing an additional 201,643 shares during the period. Global Retirement Partners LLC lifted its holdings in RadNet by 285.2% in the third quarter. Global Retirement Partners LLC now owns 470 shares of the medical research company’s stock valued at $32,000 after buying an additional 348 shares during the period. Cibc World Market Inc. bought a new stake in RadNet during the third quarter valued at $935,000. Edgestream Partners L.P. bought a new position in shares of RadNet in the 3rd quarter worth about $245,000. Finally, Teachers Retirement System of The State of Kentucky raised its position in shares of RadNet by 14.1% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 44,580 shares of the medical research company’s stock worth $3,073,000 after acquiring an additional 5,504 shares in the last quarter. Institutional investors own 77.90% of the company’s stock.
RadNet Stock Performance
NASDAQ:RDNT opened at $69.51 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.49 and a quick ratio of 1.49. The company has a market capitalization of $5.48 billion, a P/E ratio of -239.69 and a beta of 1.42. RadNet, Inc. has a 1 year low of $50.82 and a 1 year high of $85.84. The business has a fifty day simple moving average of $72.83 and a two-hundred day simple moving average of $65.56.
RadNet (NASDAQ:RDNT – Get Free Report) last announced its quarterly earnings results on Sunday, November 8th. The medical research company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.08. RadNet had a negative net margin of 0.94% and a positive return on equity of 3.14%. The company had revenue of $638.26 million for the quarter, compared to analysts’ expectations of $639.97 million. During the same period in the prior year, the company posted $0.20 EPS. RadNet’s revenue was up 22.1% compared to the same quarter last year. On average, analysts expect that RadNet, Inc. will post 0.56 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. Barclays increased their target price on shares of RadNet from $65.00 to $79.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. KeyCorp increased their price target on RadNet from $92.00 to $95.00 and gave the stock an “overweight” rating in a report on Tuesday, November 10th. Truist Financial increased their target price on RadNet from $90.00 to $94.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. Zacks Research lowered shares of RadNet from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 9th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of RadNet in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $89.67.
Read Our Latest Analysis on RadNet
Insider Buying and Selling
In related news, EVP Mital Patel sold 44,661 shares of RadNet stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $78.51, for a total transaction of $3,506,335.11. Following the completion of the sale, the executive vice president owned 155,514 shares of the company’s stock, valued at approximately $12,209,404.14. This trade represents a 22.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 5.14% of the stock is currently owned by insiders.
RadNet Profile
RadNet, Inc. operates outpatient diagnostic imaging centers in the United States. Its centers provide services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and nuclear medicine imaging. The company serves patients, physicians and healthcare organizations, with operations across several states, including California, Delaware, Florida, Maryland, New Jersey and New York. Its imaging centers offer diagnostic services for a range of medical needs, from routine screening to specialized examinations.
Featured Articles
- Five stocks we like better than RadNet
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT – Free Report).
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.
